Search results for "fibra"

showing 10 items of 172 documents

Modulador acusto-óptico en amplitud de fibra óptica basado en ondas acústicas de flexión

2014

Se reporta un estudio experimental de la operación de un modulador acusto-óptico (MAO) de fibra óptica basado en la interacción acusto-óptica producida por ondas acústicas de flexión estacionarias. Concentramos nuestra atención en los efectos de reducir el diámetro en la fibra óptica como mecanismo para optimizar la respuesta espectral del MAO. Como caso particular reportamos un modulador de 70 ¹m de diametro con una alta profundidad de modulación (60 %), bajas perdidas por inserción (1.3 dB) y un ancho ancho de banda a 3 dB de 40 nm que opera en el rango de los megahertz. Los resultados obtenidos demuestran que el incluir fibras estrechadas se puede considerar como un grado extra de libert…

//purl.org/becyt/ford/1 [https]Ciencias FísicasFísicafibras ópticas//purl.org/becyt/ford/1.3 [https]moduladores ópticosCIENCIAS NATURALES Y EXACTASÓpticadispositivos acusto-ópticos
researchProduct

Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

2020

Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid with an established benefit for patients suffering from primary biliary cholangitis (PBC). It was first introduced in the 60s and took until the late 90s to demonstrate a survival benefit in large meta-cohort studies.1 Since then, UDCA is the established first-line therapy according to current guidelines.2 The benefit of UDCA is multidimensional, and patients receiving UDCA experience increased transplant-free survival, a decreased risk of hepatocellular carcinoma and potentially improved quality of life.3–5 The survival benefit is predicted by a number biochemical markers that reflect cholestasis and that are accepted surrogates of the…

0301 basic medicineCholagogues and Cholereticsmedicine.medical_specialty2312Cholangitismedicine.drug_classBiliary cirrhosisclinical decision makingliverGastroenterologyhepatobiliary disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePrimary biliary cirrhosisCholestasisInternal medicinemedicineHumans1506BezafibrateHepatologyBile acidLiver Cirrhosis Biliarybusiness.industryUrsodeoxycholic AcidGastroenterologyObeticholic acidmedicine.diseaseUrsodeoxycholic acidLiver Transplantationprimary biliary cirrhosis030104 developmental biologychemistryHepatocellular carcinoma030211 gastroenterology & hepatologybusinessmedicine.drugGut
researchProduct

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

2017

Background and Aims: Drug-induced steatosis is a major reason for drug failure in clinical trials and post-marketing withdrawal; and therefore, predictive biomarkers are essential. These could be particularly relevant in non-alcoholic fatty liver disease (NAFLD), where most patients show features of the metabolic syndrome and are prescribed with combined chronic therapies, which can contribute to fatty liver. However, specific biomarkers to assess the contribution of drugs to NAFLD are lacking. We aimed to find microRNAs (miRNAs) responsive to steatotic drugs and to investigate if they could become circulating biomarkers for drug induced steatosis. Methods: Human HepG2 cells were treated wi…

0301 basic medicineDrugFarmacologiaMicroarraymedia_common.quotation_subjectBiologyPharmacology03 medical and health scienceshepatosteatosisCyclosporin amedicinePharmacology (medical)predictive biomarkermedia_commonOriginal ResearchPharmacologyFenofibratemicroRNAFatty livernon-alcoholic fatty liver diseasemedicine.diseasePatologiadrug-induced steatosis030104 developmental biologymetabolic syndrome drugDroguesSteatosisMetabolic syndromeTamoxifenmedicine.drugFrontiers in Pharmacology
researchProduct

Investigating fibrosis and inflammation in an ex vivo NASH murine model.

2020

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, characterized by excess fat accumulation (steatosis). Nonalcoholic steatohepatitis (NASH) develops in 15–20% of NAFLD patients and frequently progresses to liver fibrosis and cirrhosis. We aimed to develop an ex vivo model of inflammation and fibrosis in steatotic murine precision-cut liver slices (PCLS). NASH was induced in C57Bl/6 mice on an amylin and choline-deficient l-amino acid-defined (CDAA) diet. PCLS were prepared from steatohepatitic (sPCLS) and control (cPCLS) livers and cultured for 48 h with LPS, TGFβ1, or elafibranor. Additionally, C57Bl/6 mice were placed on CDAA diet for 12 wk to receive elafibranor…

0301 basic medicineLipopolysaccharidesLiver CirrhosisMalePhysiologyHEPATOCYTESLiver diseaseMice0302 clinical medicineChalconesFibrosisNon-alcoholic Fatty Liver DiseaseNonalcoholic fatty liver diseaseCells CulturedINSULIN-RESISTANCEGastroenterologyElafibranorTGF-BETALiver030211 gastroenterology & hepatologyCHOLINE-DEFICIENT DIETEXPRESSIONmedicine.medical_specialtyEARLY-ONSETIn Vitro TechniquesCollagen Type IProinflammatory cytokineTransforming Growth Factor beta103 medical and health sciencesIn vivoPhysiology (medical)Internal medicinemedicineAnimalsHEPATIC STEATOSISFATTY LIVER-DISEASEInflammationPRECISION-CUT LIVERHepatologybusiness.industrymedicine.diseaseLipid MetabolismDietMice Inbred C57BLDisease Models Animal030104 developmental biologyEndocrinologyPROLIFERATOR-ACTIVATED RECEPTORSSteatosisPropionatesbusinessTranscriptomeEx vivoAmerican journal of physiology. Gastrointestinal and liver physiology
researchProduct

Parametrical Optomechanical Oscillations in PhoXonic Whispering Gallery Mode Resonators

2019

AbstractWe report on the experimental and theoretical analysis of parametrical optomechanical oscillations in hollow spherical phoxonic whispering gallery mode resonators due to radiation pressure. The optically excited acoustic eigenmodes of the phoxonic cavity oscillate regeneratively leading to parametric oscillation instabilities.

0301 basic medicinePhysics::Opticslcsh:MedicineArticlemicrobubbles03 medical and health sciencesResonatorwhispering gallery mode resonators0302 clinical medicineOpticswhispering gallery modeslcsh:SciencePhysicsMultidisciplinarymicrobubble resonatorsbusiness.industryParametric oscillationlcsh:RUNESCO::FÍSICA::Óptica ::Fibras ópticasstimulated brillouin scatteringkerr modulation030104 developmental biologyRadiation pressureOptics and photonics:FÍSICA::Óptica ::Fibras ópticas [UNESCO]Excited stateOther photonicsparametrical optomechanical oscillationslcsh:QWhispering-gallery wavebusiness030217 neurology & neurosurgeryScientific Reports
researchProduct

Protective effects of bezafibrate against elaidic acid-induced accumulation of lipid droplets in monocytic cells

2016

Some factors related to diet, such as trans fatty acids (TFA), are known to be involved in the progression of atherosclerosis in humans. Thus, the aim of our study was (i) to evaluate the effects of three dietary free fatty acids (FFA) (elaidic (EA), oleic (OA) and palmitic acid (PA)) on U937 human monocytes, and (ii) to study the eventual benefits of bezafibrate (BZF), a pan-agonist for PPAR isoforms (α, γ and δ) in U937 cells treated with FFA. Morphologic and functional changes were investigated by microscopic and flow cytometric methods. Cellular lipid content, lipid droplets and FA composition were identified and studied. All analyses were also realized in association with or without BZ…

0301 basic medicinemedicine.medical_specialtyCD36Coronary DiseaseOleic Acids030204 cardiovascular system & hematologyMonocytesGeneral Biochemistry Genetics and Molecular BiologyPalmitic acid03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineLipid dropletmedicineHumansBezafibrateU937 cellbiologySuperoxideLipid DropletsU937 CellsGeneral MedicineElaidic acidPlaque AtheroscleroticOleic acid030104 developmental biologyEndocrinologychemistryBiochemistryCytoprotectionCase-Control Studiesbiology.proteinBezafibrateFoam Cellsmedicine.drugCurrent Research in Translational Medicine
researchProduct

Expert opinion on the metabolic complications of mTOR inhibitors

2018

Abstract Using mTOR inhibitors (mTORi) as anticancer drugs led to hyperglycemia (12–50%) and hyperlipidemia (7–73%) in phase-III trials. These high rates require adapted treatment in cancer patients. Before initiating mTORi treatment, lipid profile screening should be systematic, with fasting glucose assay in non-diabetic patients and HbA1C in diabetic patients. After initiation, lipid profile monitoring should be systematic, with fasting glucose assay in non-diabetic patients, every 2 weeks for the first month and then monthly. The HbA1C target is ≤ 8%, before and after treatment initiation in known diabetic patients and in case of onset of diabetes under mTORi. LDL-cholesterol targets sho…

0301 basic medicinemedicine.medical_specialtyConsensusEndocrinology Diabetes and MetabolismAtorvastatinAntineoplastic Agents03 medical and health sciences0302 clinical medicineEndocrinologyMetabolic DiseasesNeoplasmsInternal medicineDiabetes mellitusHyperlipidemiamedicineHumansDyslipidemiasFenofibratemedicine.diagnostic_testbusiness.industryTOR Serine-Threonine KinasesHypertriglyceridemianutritional and metabolic diseasesGeneral Medicinemedicine.diseaseHypoglycemia030104 developmental biologySimvastatin030220 oncology & carcinogenesislipids (amino acids peptides and proteins)Lipid profilebusinessPravastatinmedicine.drugAnnales d'Endocrinologie
researchProduct

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuati…

2018

A number of clinical findings suggested HDL-raising as a plausible approach to treat residual risk of CVD. However, lack of CVD risk reduction by elevated HDL cholesterol (HDL-C) through cholesterol ester transfer protein (CETP) inhibition and enhanced risk reduction in apolipoprotein A-I Milano (apoAI-M) individuals with low HDL-C shifted the focus from HDL-C level to HDL function. In the present study, we investigated correlations between HDL-C, HDL function, fecal cholesterol excretion, and ex vivo plasma cholesterol efflux capacity (CEC) in animal models using two HDL modulators, LXR and PPAR-α agonists. In C57Bl mice, LXR agonist, T1317, raised HDL-C by 30%, while PPAR-α agonist, fenof…

0301 basic medicinemedicine.medical_specialtySettore MED/09 - Medicina InternaHDLApolipoprotein BPhysiology030204 cardiovascular system & hematologylcsh:Physiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePhysiology (medical)Internal medicineCholesterylester transfer proteinmedicineHDL mouse PPAR-α LXR reverse cholesterol transport cholesterol efflux ABCA1 atherosclerosisLiver X receptormouseFenofibratelcsh:QP1-981biologyCholesterolReverse cholesterol transportnutritional and metabolic diseasesreverse cholesterol transport030104 developmental biologyEndocrinologychemistryABCA1biology.proteinCholesteryl esterLXRlipids (amino acids peptides and proteins)cholesterol effluxPPAR-αmedicine.drug
researchProduct

New fourfolds from F-theory

2015

In this paper, we apply Borcea-Voisin's construction and give new examples of fourfolds containing a del Pezzo surface of degree six, which admit an elliptic fibration on a smooth threefold. Some of these fourfolds are Calabi-Yau varieties, which are relevant for the $N=1$ compactification of Type IIB string theory known as $F$-Theory. As a by-product, we provide a new example of a Calabi--Yau threefold with Hodge numbers $h^{1,1}=h^{2,1}=10$.

14J50F-theory14J32del Pezzo surface14J32; 14J35; 14J50; Calabi-Yau manifolds; Del Pezzo surfaces; Elliptic fibration; F-theory; Mathematics (all)Calabi-Yau manifoldMathematics - Algebraic GeometryCalabi-Yau manifoldsFOS: MathematicsMathematics (all)14J35Settore MAT/03 - Geometriaelliptic fibrationDel Pezzo surfaces14J32 14J35 14J50Algebraic Geometry (math.AG)
researchProduct

Advanced in-fibre acousto-optics: applications

2017

En aplicaciones en áreas como sensado, telecomunicaciones o láseres, los dispositivos fabricados enteramente en fibra óptica ofrecen interesantes ventajas con respecto a aquellos fabricados en bulk. Una de las principales ventajas consiste en evitar la necesidad de extraer la luz guiada por una fibra óptica para procesar la señal en el dominio del tiempo, lo que se traduce en menores pérdidas. Por otra parte, comparados con los dispositivos de óptica en espacio libre, los dispositivos fabricados enteramente en fibra no requieren alineamiento, lo que proporciona una mayor estabilidad desde el punto de vista mecánico. Una cualidad deseable para los componentes ópticos es la habilidad de cambi…

:FÍSICA [UNESCO]Fibra ópticaUNESCO::FÍSICAAcustoóptica
researchProduct